Influence of exercise on gastrointestinal cancer

Klinik und Poliklinik für Innere Medizin I0 个研究点目标入组 300 人开始时间: 2021年3月29日最近更新: 2024年8月19日

试验速览

暂无简介。

•Age> 18 at the time of signing the consent form
•- declaration of consent signed by the patient
•- suitable for fulfilling the requirements of the
•Study protocol in the opinion of the investigator
•- Histologically confirmed gastro-oncological tumor diagnosis (squamous cell carcinoma
•of the esophagus, adenocarcinoma of the esophagogastric junction and
•gastric cancer, colorectal cancer, pancreatic cancer, cholangiocellular carcinoma, hepatocellular carcinoma)
•- sufficient knowledge of the German language

•- significant cardiovascular disease such as heart failure Class II or higher according to the New York Heart Association classification, myocardial infarction or cerebral insult within 6 months prior to the randomization, cardiac unstable despite anti-arrhythmic therapy, arrhythmia> Grade 2 NCI CTCAE or unstable angina pectoris.
•- serious psychiatric, pulmonary, orthopedic or neurological illness
•- patients with a malignancy other than gastrointestinal tumor disease with the exception of patients who were disease-free at least five years prior tandomization and with the exception from patients with an adequate-treated and completely resected basal cell carcinoma or squamous cell carcinoma of the skin, in situ cervical, breast or prostate cancer as well as stage I uterine carcinoma
•- simultaneous participation in another clinical study while participating in this clinical study
•- possible dependence of the patient on the investigator, including spouse, children
•and close relatives of each investigator

发起方

Klinik und Poliklinik für Innere Medizin I